AUPH
NASDAQ
$15.25
Aurinia Pharmaceuticals Inc (AUPH)
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and markets therapies to treat various diseases with unmet medical needs in Japan and China. The company is headquartered in Victoria, Canada.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $17 (+11.48%)
Market Cap
$2.11B
PEG Ratio
0.02
Revenue 5Y CAGR
+42.37%
Profit Margin
44.2%
Price Chart
Valuation
Market Cap$2.11B
P/E9.58
Forward P/E18.38
PEG0.02
P/S6.89
P/B3.63
Profitability
Total Revenue (TTM)$298M
Gross Profit (TTM)$233M
EBITDA$144M
Profit Margin44.2%
Operating Margin53.3%
EPS$1.68
Financial Health
Free Cash Flow Yield7.93%
Growth & Risk
Revenue 5Y CAGR+42.37%
Beta (5Y)0.72
Sharpe Ratio1.32